CDK2 and colorectal carcinoma: This screening revealed that several inhibitors targeting CDK1/CyclinB, CDK2/CyclinE and Aurora kinases, the downstream targets of c-Myc involved in cell cycle progression [57,58], significantly inhibited the growth of the 5MP1-transfected CRC cells (Fig. S4c and d).